Serum Biomarkers Associated With Postpartum T2DM in Women With GDM

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

3099 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-05-01

Study Completion Date

2018-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Gestational diabetes mellitus (GDM) is commonly linked to the development of type 2 diabetes mellitus (T2DM). There is a need to characterize metabolic changes associated with GDM in order to find novel biomarkers for T2DM.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Biomarkers for Early Screening of Gestational Diabetes Mellitus

NCT05142020

Gestatiaonl Diabetes Mellitus Early Pregnancy

UNKNOWN

GDM and Its Consequences in Mothers and Offsprings

NCT04529889

Gestational Diabetes Mellitus Pregnancy Outcome Neurodevelopment +3 more

RECRUITING

The Study of Biomarker in Early Diagnosis of GDM by Metabolomics

NCT05733195

Gestational Diabetes Mellitus Metabolomics Detection Biomarker in Early Diagnosis

UNKNOWN

Early Prediction of Postpartum Glucose Metabolism Abnormalities in Gestational Diabetes Mellitus

NCT05670548

Gestational Diabetes Mellitus

RECRUITING

Early Screening of Gestational Diabetes Mellitus and Prospective Cohort Study of Postpartum Follow-up

NCT03825926

Gestational Diabetes Mellitus

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

GDM, a common complication of pregnancy, affects 17.8% of pregnancies worldwide per year. Women with a history of GDM have an approximately 7-fold higher risk for developing T2DM in the future than women without GDM. However, data on the factors associated with the development of T2DM in women with GDM are not widely available.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gestational Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Gestational diabetes mellitus

Women who were diagnosed GDM in 24-28 gestation weeks.

Intervention Type OTHER

There is no intervention in this study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

There is no intervention in this study.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women who were dignosed GDM.
* Women with singleton pregnancy.
* Give birth in the First Affiliated Hospital in Sun Yat-sen University.

Exclusion Criteria

* Women who were diagnosed PGDM.
* Younger than 18 years old.
* Older than 45 years old.
* Multiple pregnancy.
* Diagnosed DM before.
* Complicationg other diseases, like hypertension, thyroid diseases, etc.
* Taking any drug affect glucose and lipid metabolism.

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No